Log In
Print this Print this


Also known as: risperidone

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionOnce-monthly sustained-release formulation of risperidone using the Atrigel delivery system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationSchizophrenia
Indication DetailsTreat acute exacerbation of schizophrenia; Treat schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today